FENOFIBRIC ACID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fenofibric Acid, and what generic alternatives are available?
Fenofibric Acid is a drug marketed by Actavis Elizabeth, Alembic, Anchen Pharms, Aurobindo Pharma Ltd, Chartwell Rx, Graviti Pharms, Impax Labs Inc, Macleods Pharms Ltd, Micro Labs, Mylan Pharms Inc, Scinopharm Taiwan, and Yichang Humanwell. and is included in twelve NDAs.
The generic ingredient in FENOFIBRIC ACID is choline fenofibrate. There are one hundred and two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.
Summary for FENOFIBRIC ACID
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 115 |
| Clinical Trials: | 21 |
| Patent Applications: | 1,680 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FENOFIBRIC ACID |
| What excipients (inactive ingredients) are in FENOFIBRIC ACID? | FENOFIBRIC ACID excipients list |
| DailyMed Link: | FENOFIBRIC ACID at DailyMed |
Recent Clinical Trials for FENOFIBRIC ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chong Kun Dang Pharmaceutical | Phase 1 |
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for FENOFIBRIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for FENOFIBRIC ACID
US Patents and Regulatory Information for FENOFIBRIC ACID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200920-001 | Oct 7, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Micro Labs | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 213450-002 | Jun 16, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Yichang Humanwell | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 212562-002 | Dec 23, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Aurobindo Pharma Ltd | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 212598-001 | Jul 25, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alembic | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 208705-002 | May 12, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Graviti Pharms | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 211626-002 | Jul 18, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan Pharms Inc | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200913-002 | Mar 25, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
